cloudfront
  • info@reportsandmarkets.com
  • +44-020-3286-9338 (UK) +1-214-377-1121 (US)
  • Sign In
  • Register

Medical DevicesExtremity Reconstruction Market By Type (Upper Extremity, Lower Extremity, Partial Shoulder Replacement, Total Standard Replacement, Stemless Total Shoulder Replacement, Total Reverse Replacement, Elbow, Hand and Wrist, Hind foot Fusion, Ankle Fusion, Ankle Replacement), Biomaterials (Metallic, Polymeric, Ceramic and Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

  • RnM848499
  • |
  • 1 September, 2016
  • |
  • Global
  • |
  • 126 pages
  • |
  • Allied Market Research
  • |
  • Medical Devices

Extremities are external articulated organs, which execute various locomotive functions. The human body has four extremities, i.e., two upper limbs and two lower limbs. In the recent times, leading players have increased their focus on the extremity reconstruction market, as the joint reconstruction market especially hips and knee reconstruction segment has witnessed sluggish growth in the recent years. Extremity reconstruction market is a small segment of the orthopedic industry, but is the fastest growing market for reconstructive joint replacements. The world extremity reconstruction market was $1,833 million in 2015 and is expected to reach $3,041 million by 2022, growing at a CAGR of 7.5% from 2016 to 2022.

The world extremity reconstruction market is driven by increase in the number of joint disorders such as osteoarthritis and rheumatoid arthritis coupled with increase in geriatric population and rapid rise in lifestyle-related disorders, such as obesity and diabetes that lead to joint disorders. In addition, increasing awareness of patients for better treatment options and need for better quality of living are expected to propel the market. Changes in clinical practice patterns, technological advancements such as reversed shoulder instead of anatomic shoulder and ankle arthroplasty for treating ankle fusion, and development of minimally invasive techniques such as stemless shoulder implants are expected to boost the market growth. However, high cost factor and failures & complications associated with the surgery are expected to hamper the market growth.

The world extremity reconstruction market is segmented on the basis of product, biomaterial, and geography. Based on product, the market is segmented mainly into upper extremity reconstruction and lower extremity reconstruction. Upper extremity reconstruction segment is subsegmented into shoulder, elbow, and hand & wrist. Lower extremity reconstruction is subsegmented into foot & ankle. Shoulder replacement has the largest market share, owing to the largest patient population and technological advancements in shoulder implants such as reverse shoulder implants and stemless implants. Ankle replacement market is expected to grow at the fastest rate due to technological advancements in this sector and positive outcome of ankle replacement to regain movement of ankles. Based on biomaterial, the market is segmented into metallic, ceramic, polymer, and natural biomaterials. Metallic biomaterials segment has the highest share in the extremity reconstruction devices, as these are preferable biomaterials for joint replacement devices due to their strength. The geographical segmentation of the market includes North America, Europe, Asia-Pacific, and LAMEA. North America has the highest market share due to high awareness among patients, increased desire to improve quality of life, and technological advancements in extremity reconstruction devices in the region. Asia-Pacific is expected to witness maximum growth due to increasing expenditure on healthcare, improving healthcare infrastructure, and increasing awareness among patients.

Merger & acquisition is the mostly adopted strategy in the extremity reconstruction market. In October 2015, Wright Medical Group, Inc. and Tornier N.V. merged to form Wright Medical Group N.V. This helped Wright Medical Group N.V. to establish itself as a premier, high-growth extremities biologics company in the extremity reconstruction market. In the same year, Zimmer and Biomet merged to form Zimmer Biomet Holdings to enhance its product offerings in the extremity reconstruction market.

Below key market players are profiled in the report

DePuy Synthes (a wholly owned subsidiary of Johnson & Johnson)
Smith & Nephew plc
Stryker Corporation
Integra Lifesciences Holdings Corporation
Zimmer Biomet Holdings, Inc.
Wright Medical Group N.V.
CONMED Corporation
Acumed, Inc., Arthrex, Inc.
Skeletal Dynamics LLC.
KEY MARKET BENEFITS

The study provides an in-depth analysis of the world extremity reconstruction market along with current trends and future estimations to elucidate the imminent investment pockets.
The report provides a quantitative analysis from 2014 to 2022 to enable stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of products helps in understanding the types of products used across various geographies.
Competitive intelligence highlights the business practices followed by leading players across various regions.
Comprehensive analysis of geographical regions are provided to determine the prevailing opportunities in these geographies.
The key players of the world extremity reconstruction market have been profiled in the report, and their strategies have been analyzed thoroughly to understand the competitive outlook of the global market
Extensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders within the market framework.
KEY MARKET SEGMENTS

The world extremity reconstruction market is segmented based on product, applications, biomaterial and geography.

World Extremity Reconstruction Market By Product

Upper Extremity Reconstruction
Shoulder
Partial Shoulder Replacement
Total Standard Replacement
Stemless Total Shoulder Replacement
Total Reverse Replacement
Elbow
Hand & Wrist
Lower Extremity Reconstruction
Foot Devices
Hind foot Fusion
Other Fusions
Ankle Reconstruction Devices
Ankle Fusion
Ankle Replacement
World Extremity Reconstruction Market By Biomaterial

Metallic Biomaterial
Ceramic Biomaterial
Polymeric Biomaterial
Natural Biomaterial
World Extremity Reconstruction Market By Geography

North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
South Korea
Malaysia
Rest of Asia-Pacific
LAMEA
Brazil
Israel
South Africa
Saudi Arabia
Others

CHAPTER 1 INTRODUCTION

    1.1 Report description
    1.2 Key benefits
    1.3 Research methodology

      1.3.1 Secondary research
      1.3.2 Primary research
      1.3.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

    2.1 CXO Perspective

CHAPTER 3 MARKET OVERVIEW

    3.1 Market Definition & Scope
    3.2 Key Findings

      3.2.1 Top Investment Pockets
      3.2.2 Top Winning Strategies

    3.3 Porters Five Forces Analysis

      3.3.1 Bargaining power of suppliers
      3.3.2 Bargaining power of buyers
      3.3.3 Threat of new entrants
      3.3.4 Intensity of rivalry
      3.3.5 Threat of substitutes

    3.4 Market Share Analysis, 2015
    3.5 Market Dynamics

      3.5.1 Drivers

          3.5.1.1 Increasing incidences of joint disabling diseases, trauma anD sports injuries
          3.5.1.2 Technological advancements in the field of extremity implants
          3.5.1.3 Increasing awareness and patient preference to maintain an active lifestyle
          3.5.1.4 Obesity and diabetes epidemic increasing the risk of degenerative joint diseases

      3.5.2 Restraints

          3.5.2.1 High cost of surgeries
          3.5.2.2 Failure, complications, and revision of surgeries and lack of trained professionals

      3.5.3 Opportunities

          3.5.3.1 Huge market opportunities in the Asia-pacific region and developing countries
          3.5.3.2 New product introductions with innovative technologies

CHAPTER 4 WORLD EXTREMITY RECONSTRUCTION MARKET, BY PRODUCT

    4.1 Overview

      4.1.1 Market size and forecast

    4.2 Upper Extremity Reconstruction

      4.2.1 Key market trend
      4.2.2 Key growth factors and opportunities
      4.2.3 Market size and forecast
      4.2.4 Shoulder Replacement

          4.2.4.1 Market size and forecast
          4.2.4.2 Partial Shoulder Replacement

              4.2.4.2.1 MARKET SIZE AND FORECAST

          4.2.4.3 Total Standard Replacement

              4.2.4.3.1 MARKET SIZE AND FORECAST

          4.2.4.4 Stemless Total Shoulder Replacement

              4.2.4.4.1 MARKET SIZE AND FORECAST

          4.2.4.5 Total Reverse Replacement

              4.2.4.5.1 MARKET SIZE AND FORECAST

          4.2.4.6 Elbow replacement

              4.2.4.6.1 MARKET SIZE AND FORECAST

          4.2.4.7 Hand and wrist reconstruction

              4.2.4.7.1 MARKET SIZE AND FORECAST

    4.3 Lower Extremity Reconstruction

      4.3.1 Key market trend
      4.3.2 Key growth factors and opportunities
      4.3.3 Market size and forecast
      4.3.4 Foot Devices

          4.3.4.1 Market size and forecast
          4.3.4.2 Hindfoot Fusion Devices

              4.3.4.2.1 MARKET SIZE AND FORECAST

          4.3.4.3 Other fusion devices

              4.3.4.3.1 MARKET SIZE AND FORECAST

      4.3.5 Ankle Devices

          4.3.5.1 Market size and forecast
          4.3.5.2 Ankle fusion devices

              4.3.5.2.1 MARKET SIZE AND FORECAST

          4.3.5.3 Total Ankle replacement devices

              4.3.5.3.1 MARKET SIZE AND FORECAST

CHAPTER 5 WORLD EXTREMITY RECONSTRUCTION MARKET, BY BIOMATERIAL

    5.1 Overview

      5.1.1 Market size and forecast

    5.2 Metallic biomaterials

      5.2.1 Market size and forecast

    5.3 Ceramic biomaterials

      5.3.1 Market size and forecast

    5.4 Polymeric Biomaterials

      5.4.1 Market size and forecast

    5.5 Natural biomaterials

      5.5.1 Market size and forecast

CHAPTER 6 WORLD EXTREMITY RECONSTRUCTION MARKET, BY GEOGRAPHY

    6.1 Overview

      6.1.1 Market size and forecast

    6.2 North America

      6.2.1 Key market trends
      6.2.2 Key growth factors and opportunities
      6.2.3 Market size and forecast
      6.2.4 U.S. Market Size and Forecast
      6.2.5 Canada: Market Size and Forecast
      6.2.6 Mexico: Market Size and Forecast

    6.3 Europe

      6.3.1 Key market trends
      6.3.2 Key growth factors and opportunities
      6.3.3 Market size and forecast
      6.3.4 Germany: Market Size and Forecast
      6.3.5 France: Market Size and Forecast
      6.3.6 U.K.: Market Size and Forecast
      6.3.7 Italy: Market Size and Forecast
      6.3.8 Spain: Market Size and Forecast
      6.3.9 Rest of Europe: Market Size and Forecast

    6.4 Asia-Pacific

      6.4.1 Key market trends
      6.4.2 Key growth factors and opportunities
      6.4.3 Market size and forecast
      6.4.4 Japan: Market Size and Forecast
      6.4.5 China: Market Size and Forecast
      6.4.6 India: Market Size and Forecast
      6.4.7 South Korea: Market Size and Forecast
      6.4.8 Malaysia: Market Size and Forecast
      6.4.9 Rest of Asia-Pacific: Market Size and Forecast

    6.5 LAMEA

      6.5.1 Key market trends
      6.5.2 Key growth factors and opportunities
      6.5.3 Market size and forecast
      6.5.4 Brazil: Market Size and Forecast
      6.5.5 Israel: Market Size and Forecast
      6.5.6 Saudi Arabia: Market Size and Forecast
      6.5.7 South Africa: Market Size and Forecast
      6.5.8 Rest of LAMEA: Market Size and Forecast

CHAPTER 7 COMPANY PROFILES

    7.1 Acumed LLC

      7.1.1 Company Overview
      7.1.2 Company Snapshot
      7.1.3 Operating Business Segments
      7.1.4 Key Strategic Moves & Developments

    7.2 Arthrex, INC.

      7.2.1 Company Overview
      7.2.2 Company Snapshot
      7.2.3 Operating business segments
      7.2.4 Key Strategic Moves & Developments

    7.3 CONMED Corporation

      7.3.1 Company Overview
      7.3.2 Company Snapshot
      7.3.3 Operating business segments
      7.3.4 Business performance
      7.3.5 Key Strategic Moves & Developments

    7.4 Integra Lifesciences Holdings Corporation

      7.4.1 Company Overview
      7.4.2 Company Snapshot
      7.4.3 Operating business segments
      7.4.4 Business performance
      7.4.5 Key Strategic Moves & Developments

    7.5 Johnson & Johnson

      7.5.1 Company Overview
      7.5.2 Company Snapshot
      7.5.3 Operating business segments
      7.5.4 Business performance
      7.5.5 Key Strategic Moves & Developments

    7.6 Skeletal Dynamics LLC

      7.6.1 Company Overview
      7.6.2 Company Snapshot
      7.6.3 Operating Business Segments

    7.7 Smith & Nephew plc

      7.7.1 Company Overview
      7.7.2 Company Snapshot
      7.7.3 Operating business segments
      7.7.4 Business performance
      7.7.5 Key Strategic Moves & Developments

    7.8 Stryker Corporation

      7.8.1 Company Overview
      7.8.2 Company Snapshot
      7.8.3 Operating business segments
      7.8.4 Business performance
      7.8.5 Key Strategic Moves & Developments

    7.9 Wright Medical Group N.V.

      7.9.1 Company Overview
      7.9.2 Company Snapshot
      7.9.3 Operating business segments
      7.9.4 Business performance
      7.9.5 Key Strategic Moves & Developments

    7.10 Zimmer Biomet Holdings, Inc.

      7.10.1 Company Overview
      7.10.2 Company Snapshot
      7.10.3 Operating business segments
      7.10.4 Business performance
      7.10.5 Key Strategic Moves & Developments





Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may not print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.




REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$4,740.00
$5,910.00
$8,250.00
3,182.91
3,968.57
5,539.88
4,361.75
5,438.38
7,591.65
574,203.60
715,937.40
999,405.00
314,325.52
391,912.19
547,085.55
Add To Cart Credit card Logo

Related Reports


Reason to Buy